Dicot Pharma AB (NGM: DICOT)
Sweden
· Delayed Price · Currency is SEK
0.190
-0.017 (-8.31%)
At close: Sep 6, 2024
Dicot Pharma AB Statistics
Total Valuation
Dicot Pharma AB has a market cap or net worth of SEK 155.17 million. The enterprise value is 138.07 million.
Market Cap | 155.17M |
Enterprise Value | 138.07M |
Important Dates
The last earnings date was Friday, August 30, 2024.
Earnings Date | Aug 30, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Dicot Pharma AB has 817.56 million shares outstanding. The number of shares has increased by 179.40% in one year.
Shares Outstanding | 817.56M |
Shares Change (YoY) | +179.40% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 13.17% |
Owned by Institutions (%) | 14.96% |
Float | 660.31M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 8.89 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.71 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.67
Current Ratio | 2.67 |
Quick Ratio | 1.98 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -789.10 |
Financial Efficiency
Return on equity (ROE) is -144.43% and return on invested capital (ROIC) is -92.48%.
Return on Equity (ROE) | -144.43% |
Return on Assets (ROA) | -75.54% |
Return on Capital (ROIC) | -92.48% |
Revenue Per Employee | n/a |
Profits Per Employee | -16.98M |
Employee Count | 3 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.53% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +26.53% |
50-Day Moving Average | 0.26 |
200-Day Moving Average | 0.25 |
Relative Strength Index (RSI) | 39.52 |
Average Volume (20 Days) | 6,645,400 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -52.19M |
Pretax Income | -50.94M |
Net Income | -50.94M |
EBITDA | -52.18M |
EBIT | -52.19M |
Earnings Per Share (EPS) | -0.07 |
Balance Sheet
Cash & Cash Equivalents | 17.10M |
Total Debt | n/a |
Net Cash | 17.10M |
Net Cash Per Share | 0.02 |
Equity (Book Value) | 17.45M |
Book Value Per Share | 0.02 |
Working Capital | 17.45M |
Cash Flow
Operating Cash Flow | -51.76M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Dicot Pharma AB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -179.40% |
Shareholder Yield | -179.40% |
Earnings Yield | -36.19% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |